ArticleBMC gastroenterology2026

ADGRF4 and ADGRL4 as novel prognostic biomarkers and potential therapeutic implications in stomach adenocarcinoma.

Jia-Hui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.